ERYtech Pharma Appoints Two New Independent Board Members

ERYtech Pharma Appoints Two New Independent Board Members

ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative 'tumor starvation' treatments for acute leukemia and other oncology indications with unmet medical needs, announces it has appointed Dr Martine George and Mrs Hilde Windels as new independent members to its board of directors.